This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Porcine Gastric inhibitory Polypeptide (GIP) ELISA Kit-Competitive
Product Overview
BioVenic Porcine Gastric inhibitory Polypeptide (GIP) ELISA Kit-Competitive is designed for the quantitative determination of Porcine Gastric inhibitory Polypeptide (GIP) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only. Sandwich ELISA assay kit targeting Porcine Gastric inhibitory Polypeptide (GIP) is available. Please inquiry for more information.
Specifications
Target Information
Gastric inhibitory Polypeptide is encoded by the GIP gene in pigs. GIP, also known as glucose-dependent insulinotropic polypeptide or glucose-dependent insulinotropic peptide, serves as a weak inhibitor of gastric acid secretion. Its primary role, as an incretin, is to stimulate insulin secretion. Alongside glucagon-like peptide-1 (GLP-1), GIP belongs to a class of molecules known as incretins, which enhance insulin release upon oral food intake. It was first isolated from porcine small intestine in 1973 for its ability to inhibit gastric hydrochloric acid secretion. GIP is a weak inhibitor of acid secretion and a potent stimulator of postprandial insulin.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.